Cytolytic P2X purinoceptors. 1998

F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
Department of Experimental and Diagnostic Medicine, Section of General Pathology, University of Ferrara, Italy. fdv@ifeuniv.unife.it

Anecdoctal evidence accumulated over almost 20 years has shown that many different cell types are killed by sustained exposure to high concentrations of extracellular ATP. The plasma membrane receptors involved have been pharmacologically characterized and cloned during the last 3 years, and named purinergic P2X. P2X receptors share an intriguing structural relatedness with Caenorhabditis elegans degenerins and mammalian amiloride-sensitive Na channels (ENaCs). Depending on the ATP dose, length of stimulation and receptor subtype, P2X receptor stimulation may cause necrosis or apoptosis. The intracellular pathways activated are poorly known, but the perturbation in intracellular ion homeostasis clearly plays a major role. ICE proteases (caspases) are also triggered, nonetheless their activation is not requested for ATP-dependent cell death. The physiological meaning of P2X receptor-dependent cytotoxicity is not understood, but an involvement in immune-mediated reactions is postulated.

UI MeSH Term Description Entries
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D018048 Receptors, Purinergic P2 A class of cell surface receptors for PURINES that prefer ATP or ADP over ADENOSINE. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system. ADP Receptors,ATP Receptors,P2 Purinoceptors,Purinergic P2 Receptors,Receptors, ADP,Receptors, ATP,ADP Receptor,ATP Receptor,P2 Purinoceptor,Receptor, Purinergic P2,P2 Receptor, Purinergic,P2 Receptors, Purinergic,Purinergic P2 Receptor,Purinoceptor, P2,Purinoceptors, P2,Receptor, ADP,Receptor, ATP

Related Publications

F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
August 2006, Pflugers Archiv : European journal of physiology,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
October 1999, Sheng li ke xue jin zhan [Progress in physiology],
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
December 1995, Naunyn-Schmiedeberg's archives of pharmacology,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
January 1994, Pharmacology & therapeutics,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
May 1995, Trends in pharmacological sciences,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
May 1998, Journal of cardiovascular pharmacology,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
January 2011, Handbook of experimental pharmacology,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
December 2007, Clinical and experimental pharmacology & physiology,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
December 1993, Naunyn-Schmiedeberg's archives of pharmacology,
F Di Virgilio, and P Chiozzi, and S Falzoni, and D Ferrari, and J M Sanz, and V Venketaraman, and O R Baricordi
January 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Copied contents to your clipboard!